Special Issue “Epigenetic Genes, Biomarkers and Immunotherapy in Cancers”

Urszula Oleksiewicz

doi:10.3390/ijms27177628

August 26, 2026International Journal of Molecular SciencesOpen Access

Special Issue “Epigenetic Genes, Biomarkers and Immunotherapy in Cancers”

View Full Paper

Ask AI

Bookmark

Share

Key Points

To summarize recent developments in how epigenetic alterations, novel biomarkers, and immune evasion mechanisms drive malignancy and dictate cancer immunotherapy responses.
Synthesized molecular findings from selected studies addressing epigenetic gene regulation, oncogenic signaling, and cell death evasion pathways.
Evaluated preclinical and translational cancer models assessing biomarker identification and combined epigenetic-immunotherapy treatment strategies.
Epigenetic dysregulation and accumulated somatic mutations jointly promote uncontrolled cell viability and resistance to programmed cell death under stressful microenvironments.
Targeting specific epigenetic modifications restores immune recognition, improving the efficacy of checkpoint inhibitors and related immunotherapeutic approaches.

No abstract yet

We only have this paper's title and publication details.

Read it at the source

Implication

Review uncovers epigenetic mechanisms and biomarkers across diverse cancers, highlighting promising therapeutic targets for personalized immunotherapy.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Urszula Oleksiewicz (2026) studied this question.

synapsesocial.com/papers/6a9299088e5d7d1fc0c10c48 https://doi.org/10.3390/ijms27177628

View Full Paper

Ask AI

Bookmark

Share

Special Issue “Epigenetic Genes, Biomarkers and Immunotherapy in Cancers”

Key Points

No abstract yet

Implication

Discussion

Cite This Study

Special Issue “Epigenetic Genes, Biomarkers and Immunotherapy in Cancers”

Key Points

No abstract yet

Implication

Discussion

Cite This Study

Keep reading

Keep reading